266 related articles for article (PubMed ID: 32558301)
1. Controlling PROTACs with Light.
Verma S; Manna D
ChemMedChem; 2020 Jul; 15(14):1258-1261. PubMed ID: 32558301
[TBL] [Abstract][Full Text] [Related]
2. Light-Induced Protein Degradation with Photocaged PROTACs.
Xue G; Wang K; Zhou D; Zhong H; Pan Z
J Am Chem Soc; 2019 Nov; 141(46):18370-18374. PubMed ID: 31566962
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule PROTACs: novel agents for cancer therapy.
Wan Y; Yan C; Gao H; Liu T
Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707
[TBL] [Abstract][Full Text] [Related]
4. PROTAC-DB: an online database of PROTACs.
Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.
An S; Fu L
EBioMedicine; 2018 Oct; 36():553-562. PubMed ID: 30224312
[TBL] [Abstract][Full Text] [Related]
6. PROTACs: A novel strategy for cancer therapy.
Liu J; Ma J; Liu Y; Xia J; Li Y; Wang ZP; Wei W
Semin Cancer Biol; 2020 Dec; 67(Pt 2):171-179. PubMed ID: 32058059
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.
Goracci L; Desantis J; Valeri A; Castellani B; Eleuteri M; Cruciani G
J Med Chem; 2020 Oct; 63(20):11615-11638. PubMed ID: 33026811
[TBL] [Abstract][Full Text] [Related]
8. Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation.
Xu H; Ohoka N; Inoue T; Yokoo H; Demizu Y
Bioorg Med Chem Lett; 2024 Jul; 107():129778. PubMed ID: 38702019
[TBL] [Abstract][Full Text] [Related]
9. PROTACs: New method to degrade transcription regulating proteins.
Hu B; Zhou Y; Sun D; Yang Y; Liu Y; Li X; Li H; Chen L
Eur J Med Chem; 2020 Dec; 207():112698. PubMed ID: 32858471
[TBL] [Abstract][Full Text] [Related]
10. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
[TBL] [Abstract][Full Text] [Related]
11. VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives.
Wang C; Zhang Y; Wang J; Xing D
Eur J Med Chem; 2022 Jan; 227():113906. PubMed ID: 34656901
[TBL] [Abstract][Full Text] [Related]
12. PROTACs to address the challenges facing small molecule inhibitors.
MartÃn-Acosta P; Xiao X
Eur J Med Chem; 2021 Jan; 210():112993. PubMed ID: 33189436
[TBL] [Abstract][Full Text] [Related]
13. Optochemical Control of Protein Degradation.
Wu P; Manna D
Chembiochem; 2020 Aug; 21(16):2250-2252. PubMed ID: 32227452
[TBL] [Abstract][Full Text] [Related]
14. Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs.
Gong L; Cui D; Xiong X; Zhao Y
Adv Exp Med Biol; 2020; 1217():317-347. PubMed ID: 31898236
[TBL] [Abstract][Full Text] [Related]
15. A modular PROTAC design for target destruction using a degradation signal based on a single amino acid.
Shanmugasundaram K; Shao P; Chen H; Campos B; McHardy SF; Luo T; Rao H
J Biol Chem; 2019 Oct; 294(41):15172-15175. PubMed ID: 31511327
[TBL] [Abstract][Full Text] [Related]
16. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
17. Targeted protein degradation: A promise for undruggable proteins.
Samarasinghe KTG; Crews CM
Cell Chem Biol; 2021 Jul; 28(7):934-951. PubMed ID: 34004187
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs).
Tomaselli D; Mautone N; Mai A; Rotili D
Eur J Med Chem; 2020 Dec; 207():112750. PubMed ID: 32871345
[TBL] [Abstract][Full Text] [Related]
19. The role of reversible and irreversible covalent chemistry in targeted protein degradation.
Kiely-Collins H; Winter GE; Bernardes GJL
Cell Chem Biol; 2021 Jul; 28(7):952-968. PubMed ID: 33789091
[TBL] [Abstract][Full Text] [Related]
20. PhotoPROTACs: A Novel Biotechnology for Cancer Treatment.
Wang ZW; Liu Y; Zhu X
Trends Cell Biol; 2020 Oct; 30(10):749-751. PubMed ID: 32855019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
